文献速递神经肿瘤

非恶性脑膜瘤的不典型组织病理学特征与治疗失败风险:多中心分析

Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis.
PubMed 文献 · World Neurosurg · 2019-10-09

该多中心研究汇总了2001至2015年间2个学术中心334例WHO I级(275例)和II级(59例)脑膜瘤手术患者,分析不典型组织病理学特征对无进展/复发生存的预后价值。中位随访52个月,不典型特征数量越多,进展/复发风险越高(log-rank P=0.001)。多因素分析显示不典型特征数量、每10个高倍视野≥4个核分裂、次全切除及未行辅助放疗与进展/复发独立相关。

要点

  • 不典型特征数量增加与进展/复发风险升高相关(log-rank P=0.001)。
  • 多因素分析中次全切除的HR为3.9(95%CI 2.5-6.3),风险最高。
  • 每10个高倍视野≥4个核分裂、未行辅助放疗及不典型特征数量均为独立危险因素。

核心结论

  • 不典型特征数量增加、每10个高倍视野≥4个核分裂、次全切除及未行辅助放疗与WHO I-II级脑膜瘤的进展/复发独立相关。

研究设计与样本

  • 多中心回顾性分析,汇总2个学术中心2001至2015年间接受手术切除的334例WHO I级(n=275)和II级(n=59)非恶性脑膜瘤患者数据。

主要发现

  • 中位随访52个月,按不典型特征数量分层:0个(n=151)、1个(n=71)、2个(n=66)、3个(n=22)、4或5个(n=24)。
  • 不典型特征数量越多,进展/复发风险越高(log-rank检验,P=0.001)。
  • 5年进展/复发 actuarial 率:0个16.3%(95%CI 10.7-24.4);1个21.7%(95%CI 12.8-35.2);2个28.2%(95%CI 18.4-41.7);3个30.4%(95%CI 13.8-58.7);4或5个51.4%(95%CI 31.7-74.5)。
  • 单因素分析中,高核/质比(P=0.007)、显著核仁(P=0.007)和坏死(P<0.00005)与进展/复发风险增加相关。
  • 多因素分析中,不典型特征数量(HR 1.30;95%CI 1.03-1.63;P=0.03)、每10个高倍视野≥4个核分裂(HR 2.45;95%CI 1.17-5.15;P=0.02)、次全切除(HR 3.9;95%CI 2.5-6.3;P<0.0005)及未行辅助放疗(HR 2.40;95%CI 1.19-4.80;P=0.01)与进展/复发风险增加相关。

临床怎么用

  • 作者认为,具有上述特征的患者可能从强化治疗中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Histopathological grading of meningiomas is insufficient for optimal risk stratification. The purpose of the present study was to determine the prognostic value of atypical histopathological features across all nonmalignant meningiomas (World Health Organization [WHO] grade I-II). METHODS: The data from 334 patients with WHO grade I (n = 275) and grade II (n = 59) meningiomas who had undergone surgical resection from 2001 to 2015 at 2 academic centers were pooled. Progression/recurrence (P/R) was determined radiographically and measured from the date of surgery. RESULTS: The median follow-up was 52 months. The patients were stratified by the number of atypical features: 0 (n = 151), 1 (n = 71), 2 (n = 66), 3 (n = 22), and 4 or 5 (n = 24). The risk of P/R increased with an increasing number of atypical features (log-rank test, P = 0.001). The 5-year actuarial rates of P/R stratified by the number of atypical features were as follows: 0, 16.3% (95% confidence interval [CI], 10.7-24.4); 1, 21.7% (95% CI, 12.8-35.2); 2, 28.2% (95% CI, 18.4-41.7); 3, 30.4% (95% CI, 13.8-58.7); and 4 or 5, 51.4% (95% CI, 31.7-74.5). On univariate analysis, the presence of high nuclear/cytoplasmic ratio (P = 0.007), prominent nucleoli (P = 0.007), and necrosis (P < 0.00005) were associated with an increased risk of P/R. On multivariate analysis, the number of atypical features (hazard ratio [HR], 1.30; 95% CI, 1.03-1.63; P = 0.03), ≥4 mitoses per high-power fields (HR, 2.45; 95% CI, 1.17-5.15; P = 0.02), subtotal resection (HR, 3.9; 95% CI, 2.5-6.3; P < 0.0005), and the lack of adjuvant radiotherapy (HR, 2.40; 95% CI, 1.19-4.80; P = 0.01) were associated with an increased risk of P/R. CONCLUSIONS: An increased number of atypical features, ≥4 mitoses per 10 high-power fields, subtotal resection, and the lack of adjuvant radiotherapy were independently associated with P/R of WHO grade I-II meningiomas. Patients with these features might benefit from intensified therapy.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lamba N, Hwang WL, Kim DW, et al. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2019. PMID: 31605839. doi:10.1016/j.wneu.2019.10.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。